Dr. Gerald Post

Dr. Gerald Post, holding qualifications of DVM, MEM, and DACVIM, serves as the Chief Medical Officer specializing in veterinary oncology. He has played a pivotal role in advancing precision medicine for canine cancers, working closely with a network of 143 clinics and 180 veterinary oncologists nationwide. Dr. Post’s research focuses on the relationship between genetics and disease outcomes in canine cancers, contributing to the creation of the world’s largest proprietary cancer data set. His belief that insights from veterinary oncology can enhance understanding in human oncology has fueled interdisciplinary studies, with his findings published in esteemed journals such as Nature Scientific Reports and Wiley Veterinary and Comparative Oncology. Dr. Post advocates for targeted therapies that utilize genetic markers specific to each canine’s cancer, employing treatments like FidoCure® for conditions including hemangiosarcoma, bladder cancer, and histiocytic sarcoma. He also supports the use of DNA sequencing to identify genetic markers in canine cancer cases, enhancing the precision and effectiveness of treatment protocols.